Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

RotaTeq

- PMLiVE

Merck misses revenue targets as Singulair slumps

Asthma drug hit hard by generic competition in the US

Novartis building

France, Germany and Spain join list of countries banning Novartis vaccines

Flu vaccines Agrippal and Fluad withdrawn after some batches found to be contaminated

EU flag

Europe misses flu vaccine target for at-risk groups

Netherlands only country where coverage is at recommended level, says WHO

- PMLiVE

GSK reverses closure of Irish manufacturing facility

But will initially cut staff numbers at Stiefel's Sligo plant by a third

- PMLiVE

Merck & Co pays €110m upfront for AiCuris’ CMV portfolio

Lead candidate is orphan drug letermovir for transplant patients

- PMLiVE

Merck says osteoporosis drug clears phase II trial

Odanacatib on track for 2013 filing

- PMLiVE

GSK expands open-source research project in TB

Opens up compound library and extends data transparency project

GSK partners with Aeras on TB vaccine

Will begin phase II trials in Kenya, India and South Africa

- PMLiVE

Merck & Co relocates global headquarters

Leaves Whitehouse Station for new site in New Jersey

- PMLiVE

Pakistan to use GSK’s Synflorix in national pneumococcal vaccination programme

Company will supply it at 90 per cent discount through the GAVI Alliance

- PMLiVE

GSK discontinues development of Anacor antibiotic

Patients developed resistance to compound during trial

- PMLiVE

Takeda pays $60m for vaccine company LigoCyte

Gains first-in-class norovirus candidate and new vaccine platform

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links